A new legal battle has emerged in the Southern District of Ohio, capturing the attention of investors and corporate governance enthusiasts alike. Jyothiswaroop Jayaprakash has filed a Verified Shareholder Derivative Complaint against Bath & Body Works, Inc., and several of its current and former directors and officers on February 27, 2026. The complaint accuses these individuals of breaching their fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, waste of corporate assets, and violations of federal securities laws.
The case revolves around allegations that from June 4, 2024, to November 19, 2025, Bath & Body Works’ leadership made false and misleading statements about the company’s financial health and strategic initiatives. The plaintiff claims that during this period, the company overstated the success of its growth strategy focusing on new product categories like men’s products, lips, hair care, and laundry items. According to Jayaprakash’s filing, these misrepresentations were part of a broader scheme to artificially inflate stock prices while insiders sold shares for significant personal gain. For instance, Defendant Gina Boswell allegedly sold over $725k worth of stock based on non-public information before the company’s disappointing financial performance was revealed.
The complaint highlights a series of public statements made by Bath & Body Works that painted an overly optimistic picture of its financial outlook. On June 4, 2024, the company reported net sales exceeding expectations despite weaker international market results. Subsequent reports continued this trend until August 28, 2025, when the truth began to surface with underwhelming earnings results for Q2 FY2025. This led to a significant drop in stock price as investors reacted to revised guidance that reflected less favorable conditions than previously communicated.
Jayaprakash argues that these actions not only misled shareholders but also resulted in substantial financial damage to Bath & Body Works itself. Between June 2024 and October 2025 alone, the company repurchased over $629 million worth of its own shares at inflated prices—a move that ultimately cost it approximately $321 million more than if accurate information had been disclosed.
In seeking justice through this derivative action—whereby a shareholder sues on behalf of the corporation—the plaintiff is demanding restitution for damages incurred due to these alleged breaches by corporate leaders. Specifically sought are compensatory damages related to losses suffered by Bath & Body Works because of insider trading activities conducted under false pretenses; disgorgement or repayment from those who profited unjustly; improvements in internal controls within management structures so similar issues do not arise again; along with any other relief deemed appropriate by court proceedings.
Representing Jayaprakash are attorneys from various law firms specializing in securities litigation while defending parties include high-profile legal teams familiar with corporate defense strategies involving complex regulatory matters such as those presented here today before Judge Algenon L Marbley (Case ID: 2:26-cv-00245).
Source: 226cv00245_Jayaprakash_v_Heaf_Complaint_Southern_District_Ohio.pdf
